izpis_h1_title_alt

Overcoming drug impurity challenges in amorphous solid dispersion with rational development of biorelevant dissolution-permeation method
ID Huzjak, Tilen (Avtor), ID Jakasanovski, Ognen (Avtor), ID Berginc, Katja (Avtor), ID Puž, Vid (Avtor), ID Zajc-Kreft, Katarina (Avtor), ID Jeraj, Žiga (Avtor), ID Janković, Biljana (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,98 MB)
MD5: DADD2338D2320295D1A14229F5BC2F9D
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0928098723002841 Povezava se odpre v novem oknu

Izvleček
Hot-melt extrusion is often used to prepare amorphous solid dispersion to overcome low drug solubility and enhance bio-performance of the formulation. Due to the uniqueness of each drug - polymer combination and its physico-chemical properties, setting the appropriate HME barrel temperature, feed rate and screw speed ensures drug amorphization, absence of residual crystallinity, absence of water, and a suitable drug release profile. In this research, samples with BCS II/IV model drug and PVP/VA polymer were prepared to evaluate the impact of HME process parameters, incoming drug form (anhydrous vs. hydrate), and drug supplier (i.e., impurity profile), on biorelevant drug release. This study provides a relationship between observed in vitro supersaturation and precipitation behavior of amorphous solid dispersion formulation with in vivo results, on patients, by using the acceptor profile of side-by-side dissolution-permeation apparatus. An in vitro dissolution method, in small volumes, in an apparatus with paddles and dissolution-permeation side-by-side method was developed on the MicroFlux™ apparatus to assess if the differences observed in vitro bears relevance to the bioequivalence outcome in vivo. The former was used to guide the generic drug product development due to high discriminatory strength, while the latter was biorelevant, due to the inclusion of the second compartment assuring absorptive environment to capture the impact of supersaturation and subsequent precipitation on bioavailability. Bio-relevancy of the in vitro method was confirmed with the in vivo dog study and clinical study on patients, and an in vitro - in vivo correlation was established. For the investigated BCS II/IV drug, this research highlights the importance of considering supersaturation and formation of colloidal species during amorphous solid dispersion release testing to assure product quality, safety and efficacy.

Jezik:Angleški jezik
Ključne besede:biorelevant dissolution-permeation, hot-melt extrusion, In vitro – in vivo correlation, liquid-liquid phase separation, solid dispersion, supersaturation
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:12 str.
Številčenje:Vol. 192, art. 106655
PID:20.500.12556/RUL-155631 Povezava se odpre v novem oknu
UDK:544.351.3:615.45
ISSN pri članku:0928-0987
DOI:10.1016/j.ejps.2023.106655 Povezava se odpre v novem oknu
COBISS.SI-ID:188116227 Povezava se odpre v novem oknu
Datum objave v RUL:09.04.2024
Število ogledov:453
Število prenosov:202
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:European Journal of Pharmaceutical Sciences
Skrajšan naslov:Eur. j. pharm. sci.
Založnik:Elsevier
ISSN:0928-0987
COBISS.SI-ID:17553413 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-ND 4.0, Creative Commons Priznanje avtorstva-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nd/4.0/deed.sl
Opis:Licenca Creative Commons Brez predelav dovoljuje uporabnikom ponovno distribucijo dela, vendar ne v spremenjeni obliki. Zahtevana je navedba avtorstva.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:farmacevtske oblike, topnost, biorelevantno raztapljanje-prepustnost, ekstrudiranje z vročim taljenjem, in vitro – in vivo korelacija, ločevanje tekoče-tekoče faze, trdna disperzija, prenasičenost

Projekti

Financer:Drugi - Drug financer ali več financerjev
Številka projekta:MA-16430-2020

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0189
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj